SLC2A1 and gastric cancer: Oleanolic acid inhibited gastric cancer glycolysis by down-regulating the expression of HIF-1α, and celastrol inhibited the expression of GLUT1, HK2, and LDH, thereby inhibiting glycolysis in gastric cancer cells.